Search

everythinglearnresearchcommunity

for

Search:↓

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Female pattern hair loss affects crown, increases with age, and has limited treatments.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Bald men may have a lower risk of testicular cancer.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Antiandrogen therapy may help treat hidradenitis suppurativa.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Finasteride treatment changes Cx43 in rat testes, possibly causing fertility issues.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

The document concludes that more research is needed to fully understand the causes of PCOS.